Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Nano-X Imaging Ltd.NASDAQ: NNOX

Cost of Revenue · Q4 FY2025 · quarter ended Dec 2025

Cost of revenue growth accelerates

Q4 FY2025 cost of revenue of $7.34M rose 24.6% year over year, ahead of the +17.4% change in trailing-twelve-month cost of revenue. Sequentially, it rose 15.9% from the prior quarter. Over 3 fiscal years it compounded at +18.6% a year.

Context

  • Cost of revenue amounted to 198.2% of revenue in FY2025, up 4.2 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +24.6% holds above the trailing-twelve-month pace of +17.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
$7.34M+15.9% QoQ
Last fiscal yearDec 2025
$25.81M+17.9% YoY
LTMDec 2025
$25.81M+17.4% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+24.6%——
1 year+17.9%——
3-year CAGR+18.6%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
25.81M USD
Year-over-year change
+17.9%
4-year CAGR
+74.0%

Cost of Revenue vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 cost of revenue of $25.81M is the 5th highest of the 11 companies compared; the peer median is $8.74M.
  • Its year-over-year change of +17.4% is the 4th highest of 10, against a peer median of -1.6%.
  • Cost of revenue amounts to 198.2% of revenue for NNOX, versus a peer median of 40.1%.
NNOX Competitors Peer median
Cost of Revenue for NNOX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INGNInogen, Inc.LTM Mar 2026$180.21M -1.6%-6.5%51.3%
HCATHealth Catalyst, Inc.LTM Mar 2026$163.38M -4.2%+13.1%54.0%
QTRXQuanterix CorporationLTM Mar 2026$80.87M +47.8%+7.1%55.8%
OMOutset Medical, Inc.LTM Mar 2026$69.8M -5.5%-9.3%59.4%
NNOXNano-X Imaging Ltd.LTM Dec 2025$25.81M +17.4%+18.6%198.2%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$10.78M +27.5%+32.5%24.3%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$6.7M +44.8%+45.6%14.9%
MXCTMaxCyte, Inc.LTM Mar 2026$6.23M -13.4%+6.9%19.3%
PROFProfound Medical Corp.LTM Mar 2026$5.46M +17.1%+9.4%28.9%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$2.63M ——426.2%
HSDTSolana CompanyLTM Mar 2026$559K -3.6%+2.6%5.8%
Peer median (excluding NNOX) $8.74M-1.6%+7.1%40.1%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.3M8.58M9.91M11.28M13.02M
Cost of Revenue2.82M15.46M16.5M21.89M25.81M
Gross Profit(1.51M)(6.88M)(6.59M)(10.61M)(12.79M)
Gross Margin-116.0%-80.2%-66.6%-94.0%-98.2%
Research & Development17.12M26.51M26.05M20.18M19.24M
Selling, General & Admin41.74M45.63M28.39M25.75M27.1M
Operating Expenses60.05M72.33M56M46.14M47.91M
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
EBITDA(59.27M)(75.7M)(47.69M)(45.01M)(49M)
EBITDA Margin-4544.9%-882.4%-481.5%-398.9%-376.3%
Operating Income(61.56M)(109.71M)(62.59M)(56.75M)(60.7M)
Operating Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%
Interest Income0789K1.65M2.87M1.42M
Interest Expense288K0000
Other Income / Expenses(288K)(14.67M)1.47M2.87M(16.11M)
Income Before Tax(61.85M)(108.92M)(61.12M)(53.87M)(76.81M)
Pre-Tax Margin-4742.8%-1269.8%-617.0%-477.5%-589.9%
Income Tax Expense(48K)(3.68M)(339K)(358K)(1.79M)
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Net Margin-4739.1%-1226.9%-613.6%-474.3%-576.1%
EPS (Basic)(1.28)(2.01)(1.08)(0.91)(1.16)
EPS (Diluted)(1.28)(2.01)(1.08)(0.91)(1.16)
Weighted Avg Shares48.22M52.24M56.37M58.62M64.79M
Weighted Avg Shares (Diluted)48.22M52.24M56.37M58.62M64.79M

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.